
Essentra, a manufacturer of packaging for the pharmaceutical and retail industry, has revealed that it is undergoing a consultation process …

The long-awaited results for AstraZeneca’s Mystic trial have been revealed and, in a shocking setback for the company, it was …

If you’ve ever taken a course of antibiotics then you will be familiar with the piece of advice that is …

Amongst other announcements at its second quarter statement, GSK’s CEO, Emma Walmsley, gave a hint towards the British-based company’s desires …

Sanofi Pasteur Korea has announced that Baptiste de Clarens will be the new General Manager of the unit, after the …

New research, led by teams from AFM-Telethon laboratory in Nantes and the University of London, have developed a gene therapy …

The latest Phase 3 data investigating Janssen’s darunivir in the treatment of human immunodeficiency virus (HIV-1) showed that the drug …

It has been announced that Celgene has agreed to settle a case after a whistle-blower launched a lawsuit against the …

Data released by NHS Digital rings a very worn bell regarding levels of staff employed and recruited the NHS, as …

Since the PD-1/PD-L1 immunotherapies have hit the market, they have revolutionised cancer care for many patients yet, with the science …

The US faces an ongoing crisis in opioid dependency, and FDA Commissioner Scott Gottlieb is prepared to employ unusual tactics …

Cardinal Health, one of the largest drug distributors in the US, is looking to sell on its network in China, …

Eli Lilly is to enter a partnership with Nektar Therapeutics to tap into the biotech’s new autoimmune disease therapy as …

Endo International has announced that it will close down its manufacturing and distribution facilities in Huntsville, Alabama, as part of …

Context Therapeutics, a biotech company that focuses on the development of treatments for Sigma1-related diseases, has announced that a new …